Bone Loss Recruiting Phase Trials for Zoledronic acid (DB00399)

Also known as: Osteopenia / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01623908Bone Loss Treatment From Adjuvant Zoledronate EfficacyTreatment